Literature DB >> 11372705

Use of anticoccidial drugs in broiler chickens in the USA: analysis for the years 1995 to 1999.

H D Chapman1.   

Abstract

Data collected by Agri Stats Inc. in the US for the years 1995 to 1999 was evaluated to determine the types of anticoccidial drug programs used by broiler plants, their frequency and duration, and whether there was any correlation with performance of the birds. Information was available for five feed types (prestarter, starter, grower, first withdrawal, and final withdrawal). The most popular program was an ionophore (ION; principally salinomycin) in starter and grower feeds. A chemical (principally nicarbazin) was also used in the starter feed followed by an ION in the grower feed, or two different ION in the starter and grower feeds. Seasonal differences were apparent in the type of program and in the frequency of program changes. There was no consistent pattern in the sequence with which different programs were employed. There were no significant differences in calorie conversion or the number of days to produce a 2.27 kg bird, whether a single ION or a chemical followed by an ION was used, but mortality was significantly higher for the latter. For 1999, calorie conversion and mortality were higher in plants where chemical-ION programs had been used for more than 40% of the time during the previous 4 yr. The duration and frequency with which different programs were employed were similar whether birds were raised to final weights of 1.5 to 2.0 kg, 2.0 to 2.5 kg, or more than 2.5 kg. There were significant differences in the use of salinomycin and nicarbazin in different regions of the US.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11372705     DOI: 10.1093/ps/80.5.572

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  8 in total

Review 1.  Towards identifying novel anti-Eimeria agents: trace elements, vitamins, and plant-based natural products.

Authors:  Frank Wunderlich; Saleh Al-Quraishy; Holger Steinbrenner; Helmut Sies; Mohamed A Dkhil
Journal:  Parasitol Res       Date:  2014-09-04       Impact factor: 2.289

2.  Effect of Monovalent Copper Oxide and Potentiated Zinc Oxide on Growth Performance and Gut Morphology of Broiler Chickens Challenged with Coccidiosis.

Authors:  M Zaghari; S Pouraghaali; M Zhandi; M Abbasi
Journal:  Biol Trace Elem Res       Date:  2022-07-04       Impact factor: 3.738

3.  Disruption of a mitochondrial MutS DNA repair enzyme homologue confers drug resistance in the parasite Toxoplasma gondii.

Authors:  Erin M Garrison; Gustavo Arrizabalaga
Journal:  Mol Microbiol       Date:  2009-03-04       Impact factor: 3.501

4.  Identification of new leishmanicidal peptide lead structures by automated real-time monitoring of changes in intracellular ATP.

Authors:  J Román Luque-Ortega; José M Saugar; Cristina Chiva; David Andreu; Luis Rivas
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

5.  Intestinal intraepithelial lymphocytes sustain the epithelial barrier function against Eimeria vermiformis infection.

Authors:  Kyoko Inagaki-Ohara; Fitriya Nurannisa Dewi; Hajime Hisaeda; Adrian L Smith; Fumiko Jimi; Maki Miyahira; Ayman Samir Farid Abdel-Aleem; Yoichiro Horii; Yukifumi Nawa
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

6.  Vaccination of chickens against coccidiosis ameliorates drug resistance in commercial poultry production.

Authors:  H David Chapman; Thomas K Jeffers
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-10-25       Impact factor: 4.077

7.  Trypanocidal activity of salinomycin is due to sodium influx followed by cell swelling.

Authors:  Dietmar Steverding; Darren W Sexton
Journal:  Parasit Vectors       Date:  2013-03-21       Impact factor: 3.876

8.  Oxidative stress generated during monensin treatment contributes to altered Toxoplasma gondii mitochondrial function.

Authors:  Robert A Charvat; Gustavo Arrizabalaga
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.